Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations

Basic and Clinical Pharmacology and Toxicology- United States

doi 10.1111/bcpt.12946

Full Text

Abstract

Available in

Date

Authors

Publisher

Wiley

Related search

Regulatory Considerations on Endpoints in Ovarian Cancer Drug Development

Cancer
Cancer ResearchOncology
2017English

Pharmacoepidemiological Study of Potential Drug Interactions in Heart and Neurological Outpatients

International Journal of Basic & Clinical Pharmacology
2014English

Intracellular Trafficking Considerations in the Development of Natural Ligand-Drug Molecular Conjugates for Cancer

Annals of Biomedical Engineering
Biomedical Engineering
2011English

Pharmacoepidemiological Studies Using the Veterans Affairs Decision Support System

2011English

Methodological Considerations for Studies of Brain Glycogen

Journal of Neuroscience Research
Molecular NeuroscienceCellular
2019English

Peak Exposures in Epidemiologic Studies and Cancer Risks: Considerations for Regulatory Risk Assessment

Risk Analysis
QualityReliabilitySafetyRiskPhysiology
2019English

Associations Between Infectious Mononucleosis and Cancer: Record-Linkage Studies

Epidemiology and Infection
EpidemiologyInfectious Diseases
2008English

Use of Genome-Wide Association Studies for Cancer Research and Drug Repositioning

PLoS ONE
Multidisciplinary
2015English

Urine Drug Screens: Considerations for the Psychiatric Pharmacist

Mental Health Clinician
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy